Sanuwave Health (SNWV)
(Delayed Data from NSDQ)
$36.24 USD
-2.23 (-5.80%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $36.14 -0.10 (-0.28%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth NA Momentum NA VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SNWV 36.24 -2.23(-5.80%)
Will SNWV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SNWV based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for SNWV
Roth Capital Initiates Coverage on SANUWAVE Health (SNWV) with Buy Rating | SNWV Stock News
Sarepta upgraded, Tapestry downgraded: Wall Street's top analyst calls
Sanuwave Health initiated with bullish view at Roth Capital, here's why
Sanuwave Health (SNWV) Gains Buy Rating from Roth Capital
SANUWAVE Health Inc Reports Record Q2 2025 Revenue Between $10.1M and $10.2M